Efficacy of Acceptance and Commitment Therapy for the Management of Quality of Life in Patients Post Myocardial Infarction

NCT ID: NCT06548282

Last Updated: 2025-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-21

Study Completion Date

2024-09-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study aims to investigate the efficacy of acceptance and commitment therapy for the management of quality of life in patients post-myocardial infarction

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The current quantitative study is carried out in two steps. A cross-sectional survey assesses quality of life and associated factors during the first step. A randomized controlled trial will be done during the second step where patients with myocardial infarction who are identified with type D personality characteristics, psychological distress, low level of medication adherence, low social support, low quality of life, low acceptance and psychological flexibility will be randomly assigned to two groups i.e. waitlist control group and intervention group. The acceptance and commitment therapy would be implemented on participants in the interventional group. As the control group is the waitlist control group; initially no intervention will be given to participants in the control group but the intervention will be given to the control group participants once the study is completed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychological Distress Type D Personality Medication Adherence Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental

Who receives intervention i.e. Acceptance and Commitment Therapy

Group Type EXPERIMENTAL

Acceptance and commitment therapy

Intervention Type OTHER

Introduction: Build rapport and complete pre-assessment questionnaires.

First Session:

Introduce therapist, ACT principles, and MI complications. Provide psychoeducation and assign homework.

Second Session:

Review feedback and encourage change. Assign homework.

Third Session:

Discuss acceptance and coping strategies. Assign homework.

Fourth Session:

Discuss cognitive diffusion and unhelpful thoughts. Assign homework.

Fifth Session:

Explore self-concept and mindfulness. Assign homework.

Sixth Session:

Identify and elaborate on values. Assign homework.

Seventh Session:

Discuss values, goals, and barriers. Assign homework.

Eighth Session:

Discuss commitment to action and relapse prevention. Administer post-test and express gratitude.

Waitlist Control

Who would receive intervention after study completion

Group Type ACTIVE_COMPARATOR

Acceptance and commitment therapy

Intervention Type OTHER

Introduction: Build rapport and complete pre-assessment questionnaires.

First Session:

Introduce therapist, ACT principles, and MI complications. Provide psychoeducation and assign homework.

Second Session:

Review feedback and encourage change. Assign homework.

Third Session:

Discuss acceptance and coping strategies. Assign homework.

Fourth Session:

Discuss cognitive diffusion and unhelpful thoughts. Assign homework.

Fifth Session:

Explore self-concept and mindfulness. Assign homework.

Sixth Session:

Identify and elaborate on values. Assign homework.

Seventh Session:

Discuss values, goals, and barriers. Assign homework.

Eighth Session:

Discuss commitment to action and relapse prevention. Administer post-test and express gratitude.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acceptance and commitment therapy

Introduction: Build rapport and complete pre-assessment questionnaires.

First Session:

Introduce therapist, ACT principles, and MI complications. Provide psychoeducation and assign homework.

Second Session:

Review feedback and encourage change. Assign homework.

Third Session:

Discuss acceptance and coping strategies. Assign homework.

Fourth Session:

Discuss cognitive diffusion and unhelpful thoughts. Assign homework.

Fifth Session:

Explore self-concept and mindfulness. Assign homework.

Sixth Session:

Identify and elaborate on values. Assign homework.

Seventh Session:

Discuss values, goals, and barriers. Assign homework.

Eighth Session:

Discuss commitment to action and relapse prevention. Administer post-test and express gratitude.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. First-time diagnosed, non-hospitalized patients with myocardial infarction (MI).
2. Patients attending follow-up visits at the hospital.
3. Patients experiencing distress.
4. Patients exhibiting features of Type D personality.
5. Patients reporting low levels of:

* Quality of Life (QoL)
* Medication adherence
* Social support
* Acceptance
* Psychological flexibility
6. Patients aged 18 years and above.
7. Both genders.
8. Patients who can understand Urdu.
9. Patients who can provide informed consent.

Exclusion Criteria

1. Hospitalized patients with myocardial infarction (MI).
2. Patients with myocardial infarction (MI) and other chronic co-morbid diseases, such as:

* Cancer
* Cognitive deficits
* Chronic psychological disorders
3. Patients with silent myocardial infarction.
4. Patients younger than 18 years.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fatima Jinnah Women University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sehrish Khan

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sehrish Khan, PhD Scholar

Role: PRINCIPAL_INVESTIGATOR

Fatima Jinnah women University, Rawalpindi, Pakistan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Armed Forces Institute of Cardiology

Rawalpindi, Punjab Province, Pakistan

Site Status

Rawalpindi Institute of Cardiology

Rawalpindi, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FJWU/EC/2024/88

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Person Centered Nurse Led Atrial Fibrillation Care
NCT04609202 ACTIVE_NOT_RECRUITING NA